With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

Cadence Design Systems unveiled on Wednesday a new supercomputer based on chips from Nvidia that will speed up its software ...

Vinay Prasad, a skeptic of mainstream medicine, is now a top FDA official. Change is coming for some drugmakers, one way or ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

Q1 2025 Earnings Call Transcript May 6, 2025 Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $1.2 EPS, expectations were $1.38. Operator: Thank you for standing by, and welcome ...

Marea Therapeutics has linked its lead candidate to a 53% placebo-adjusted mean reduction in remnant cholesterol, positioning ...

California investment firm Vivo Capital has secured $740 million in commitments to be aimed at preclinical and clinical-stage ...

Rigel Pharmaceuticals, Inc.'s 68% YoY revenue growth signals durable stock potential. Click for my RIGL earnings update and a ...

Bio-Techne surpasses profit expectations with significant growth in its research products, leading to the announcement of a ...

Searching For Answers C-Suite Leaders Awards The San Francisco Business Times is now seeking nominations for our annual ...